NCT06517940View on ClinicalTrials.gov

A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)

Active, not recruitingOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Retinitis Pigmentosa

Trial Locations (1)

02114

Mass Eye and Ear, Boston

All Listed Sponsors

lead

Sumitomo Pharma America, Inc.

INDUSTRY